Terlipressin |
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin; (2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[ |
(CAS 14636-12-5) |
 |
Description: |
Terlipressin (trade names Teripress by New Medicon Pharma and Glypressin by Ferring Pharmaceuticals) is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices. |
Product No. |
KT10082 |
Product Name |
Terlipressin |
Synonyms |
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-d |
Formal Name |
N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin; (2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[ |
CAS Number |
14636-12-5 |
Molecular Formula |
C52H74N16O15S2 |
Formula Weight |
1227.37 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Leuprorelin Acetate
Lipopeptide Acetate
Liraglutide
Lixisenatide
Lysipressin Acetate
Matrixyl
Melanotan II
Nafarelin Acetate
Nesiritide Acetate
Octreotide
Octreotide acetate
Ornipressin Acetate
Vapreotide Acetate
Vapreotide acetate
Vasopressin Acetate
Ziconotide acetate |
|